Clinical trialPhase 1Unknown
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
A Phase 1 Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Advanced or Recurrent Malignancies
- Outcome
- Outcome unknown
- Phase
- Phase 1
- Status
- Unknown
- Study type
- Interventional
- Start
- December 2015
- Expected end
- June 2020
- Enrollment
- 51 participants
- Sites
- 1
- Primary outcomes
- Number of dose limiting Toxicities; Tmax
- Sponsor
- Industry
- Results posted
- No
- Last update
- 1 February 2019
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try